Mingxin Qian

Direct Plasma Sample Injection in Multiple-Component LC−MS−MS Assays for High-Throughput Pharmacokinetic Screening

Jing‐Tao Wu, Hang Zeng, Mingxin Qian et al. · Analytical Chemistry · 1999 · 150 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Discovery of γ-Lactam Hydroxamic Acids as Selective Inhibitors of Tumor Necrosis Factor α Converting Enzyme:  Design, Synthesis, and Structure−Activity Relationships

James J.‐W. Duan, Lihua Chen, Zelda R. Wasserman et al. · Journal of Medicinal Chemistry · 2002 · 119 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Sultam Hydroxamates as Novel Matrix Metalloproteinase Inhibitors

Robert J. Cherney, Ruowei Mo, Dayton T. Meyer et al. · Journal of Medicinal Chemistry · 2004 · 94 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, Synthesis, and Evaluation of Benzothiadiazepine Hydroxamates as Selective Tumor Necrosis Factor-α Converting Enzyme Inhibitors

Robert J. Cherney, James J.‐W. Duan, Matthew E. Voss et al. · Journal of Medicinal Chemistry · 2003 · 64 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Design and Synthesis of a Series of (2<i>R</i>)-<i>N</i>⁴-Hydroxy-2-(3-hydroxybenzyl)-<i>N</i>- [(1<i>S</i>,2<i>R</i>)-2-hydroxy-2,3-dihydro-1<i>H</i>-inden- 1-yl]butanediamide Derivatives as Potent, Selective, and Orally Bioavailable Aggrecanase Inhibitors

Wenqing Yao, Zelda R. Wasserman, Michael C. Chao et al. · Journal of Medicinal Chemistry · 2001 · 63 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17